{
  "id": "cluster_11_docid6",
  "content": "Audit RN-2204-966 highlights three cases where biologics authorization delays occurred during provider transitions at Aurora, including JK-7743-22. Recommends system-wide review of RNP-208 exceptions processing timelines for high-risk therapies.",
  "metadata": {
    "format": "audit_report"
  }
}